跳至主要内容
临床试验/NCT04529967
NCT04529967招募中不适用

Child-Parent Screening of Familial Hypercholesterolemia in Children

Children's Hospital of Fudan University6 个研究点 分布在 1 个国家目标入组 15,000 人开始时间: 2025年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
15,000
试验地点
6
主要终点
The affected status of Familial Hypercholesterolemia

研究概览

简要总结

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited premature coronary artery disease. The investigators assessed the efficacy and feasibility of such screening in primary care practice.

key scientific questions:

  1. The 95th and 99th percentile of finger blood TC in children of 2 years old.
  2. Mutations that contribute to high TC status ( serum TC >99th percentiles) compared with international FH48 panel for FH genetic screening.

详细描述

Familial hypercholesterolemia (FH) is an inherited condition resulting in high levels of low-density lipoprotein cholesterol (LDL-C) and increased risk of premature coronary artery disease in men and women. Child-parent screening for familial hypercholesterolemia has been proposed to identify persons who are carriers of FH mutations and with high risk for inherited premature coronary artery disease. The investigators will conduct a cross-sectional community-based screening in children of 2 years old to detect FH children cases using finger blood TC test first and followed by serum TC test and mutation test, and to identify and diagnose their affected parents. This study aims to established the child-parent screening program and technique issues for early diagnosis of familial hypercholesterolemia families for future early intervention.

Child-parent screening strategy in our study consists three steps: i. Capillary blood total cholesterol test of children aged around 2 years; ii. re-test for children with cholesterol>95th percentile in the first step; iii. WES (whole exome sequencing) test for >P99 in the first two steps. iV: TC test and mutation test to the parents of the child FH cases. The investigators will determine FH families based on the program. Children's Hospital of Fudan University will provide treatment further.

研究设计

研究类型
Observational
观察模型
Family Based
时间视角
Cross Sectional

入排标准

年龄范围
1 Year 至 3 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Receive routine child care
  • aged 1 - 3 years old ( date of investigate minus date of birth)

排除标准

  • It is up to the researcher to decide whether it is suitable to participate in this research

结局指标

主要结局

The affected status of Familial Hypercholesterolemia

时间窗: At enrollment

heterozygote or homozygote carriers of established FH mutations in LDLR, PSCK9 and APOB gene, including mutations included in the FH48 and new ones identified in Chinese children

次要结局

  • fasting total cholesterol level by Fingertip capillary blood test in children around 2 years old(At enrollment)
  • affected status of known FH mutation(At enrollment)
  • fasting serum LDL-c levels of children with finger TC over P95(At enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Child-Parent Familial Hypercholesterolemia Screening | 临床试验